Atlas FDA

SURGIFLO HEMOSTATIC MATRIX

FDA premarket approval P990004/S008 · decided 2005-05-05

Approval details

PMA number
P990004
Supplement
S008
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
SURGIFLO HEMOSTATIC MATRIX
Generic name
Agent, absorbable hemostatic, collagen based
Applicant
Ferrosan Meidcal Devices A/S
Date received
2005-03-10
Decision date
2005-05-05
Days to decision
56 days
Decision code
APPR
Product code
LMF
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Soeborg
Statement
APPROVAL FOR MARKETING A PRE-FILLED PASTE PREPARED FROM THE POWDERED FORM OF THE ABSORBABLE GELATIN SPONGE. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME SURGIFLO HEMOSTATIC MATRIX AND IS INDICATED FOR SURGICAL PROCEDURES (EXCEPT UROLOGIC AND OPHTHALMIC) FOR HEMOSTASIS, WHEN CONTROL OF CAPILLARY, VENOUS AND ARTERIOLAR BLEEDING BY PRESSURE, LIGATURE AND OTHER CONVENTIONAL PROCEDURES IS INEFFECTIVE OR IMPRACTICAL.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.